TrialESC heart failure2023

IGFBP7 and left ventricular mass regression: a sub-analysis of the EMPA-HEART CardioLink-6 randomized clinical trial.

Pankaj Puar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.